IFNA1 and myeloproliferative neoplasm: IFN-α, one of its isoforms, regulates the generation of the hematopoietic system by affecting human megakaryocyte precursors and immature pluripotent hematopoietic progenitor cells without increasing the risk of cellular mutagenesis, which may provide a viable treatment alternative for MPN patients [12].